Aberrant Hetero-Disulfide Bond Formation by the Hypertriglyceridemia-Associated p.Gly185Cys APOA5 Variant (rs2075291)
暂无分享,去创建一个
H. Witkowska | M. Malloy | C. Pullinger | J. Kane | J. Simonsen | A. Witkowski | T. Forte | Vineeta Sharma | R. Ryan | Andrew B Dykstra | G. Watson | S. Francisco | Jennifer A. Beckstead | L. Nelbach
[1] J. Esko,et al. Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. , 2013, The Journal of clinical investigation.
[2] T. Forte,et al. Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol , 2013, Current opinion in lipidology.
[3] J. Simonsen,et al. Gene Transfer of Apolipoprotein A-V Improves the Hypertriglyceridemic Phenotype of apoa5 (−/−) mice , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[4] S. Young,et al. Glycosylphosphatidylinositol‐anchored high‐density lipoprotein‐binding protein 1 and the intravascular processing of triglyceride‐rich lipoproteins , 2012, Journal of internal medicine.
[5] D. Mikhailidis,et al. Triglycerides: a case for treatment? , 2012, Current opinion in cardiology.
[6] J. Kao,et al. Functional importance of apolipoprotein A5 185G in the activation of lipoprotein lipase. , 2012, Clinica chimica acta; international journal of clinical chemistry.
[7] J. Aberle,et al. Resequencing the apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia. , 2011, Atherosclerosis.
[8] S. Young,et al. Binding Preferences for GPIHBP1, a Glycosylphosphatidylinositol-Anchored Protein of Capillary Endothelial Cells , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[9] V. Salomaa,et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia , 2010, Nature Genetics.
[10] S. Vaessen,et al. Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia. , 2009, Biochemical and biophysical research communications.
[11] S. Young,et al. The Acidic Domain of GPIHBP1 Is Important for the Binding of Lipoprotein Lipase and Chylomicrons* , 2008, Journal of Biological Chemistry.
[12] N. Delsaux,et al. Effects of Six APOA5 Variants, Identified in Patients With Severe Hypertriglyceridemia, on In Vitro Lipoprotein Lipase Activity and Receptor Binding , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[13] T. Forte,et al. Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice Published, JLR Papers in Press, December 3, 2007. , 2008, Journal of Lipid Research.
[14] P. Kwok,et al. patient-oriented and epidemiological research An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients , 2008 .
[15] T. Forte,et al. Apolipoprotein A-V association with intracellular lipid dropletss⃞ Published, JLR Papers in Press, April 25, 2007. , 2007, Journal of Lipid Research.
[16] Le-ming Fan,et al. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. , 2006, Atherosclerosis.
[17] L. Pennacchio,et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. , 2005, The Journal of clinical investigation.
[18] M. Nagano,et al. A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration Published, JLR Papers in Press, June 16, 2005. DOI 10.1194/jlr.D500018-JLR200 , 2005, Journal of Lipid Research.
[19] S. Nilsson,et al. Apolipoprotein A-V-heparin Interactions , 2005, Journal of Biological Chemistry.
[20] Yasushi Ishihama,et al. Proteomic LC-MS systems using nanoscale liquid chromatography with tandem mass spectrometry. , 2005, Journal of chromatography. A.
[21] A. Boodhoo,et al. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. , 2005, Clinical chemistry.
[22] K. Chien,et al. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. , 2003, Human molecular genetics.
[23] C. Kay,et al. Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. , 2003, Biochemistry.
[24] A. Shevchenko,et al. Fast-response proteomics by accelerated in-gel digestion of proteins. , 2003, Analytical chemistry.
[25] Jonathan C. Cohen,et al. An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.
[26] P. Reitsma,et al. Apolipoprotein A-V A NOVEL APOLIPOPROTEIN ASSOCIATED WITH AN EARLY PHASE OF LIVER REGENERATION* , 2001 .
[27] J. Hokanson,et al. Hypertriglyceridemia as a cardiovascular risk factor. , 1998, The American journal of cardiology.
[28] A. Shevchenko,et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. , 1996, Analytical chemistry.
[29] K. Weisgraber. Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. , 1990, Journal of lipid research.
[30] M. Jauhiainen,et al. Interaction of lipoprotein(a) with fibronectin and its potential role in atherogenesis. , 1990, European heart journal.